The antiviral combination nirmatrelvir-ritonavir (Paxlovid) used for early symptoms of COVID-19 offers limited protection against the development of Long COVID.
Kenneth Bender, PharmD
Advertisement
Articles by Kenneth Bender, PharmD
Combining the two drugs appears more likely to reduce risk of early COVID-19 symptoms worsening than taking either one on its own.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Drug Topics
1
Vaccination of 3 Or More Doses Reduces Incidence of COVID-19 Symptoms for Young Adults
2
FDA Approves First 1-Minute Self Test for HIV
3
Orforglipron Demonstrates Superior Glycemic Control for Type 2 Diabetes
4
CVS Pharmacy Acquires Select Rite Aid Assets in 3 States, Accounting for Over 600 Stores
5
